Found: 18
Select item for more details and to access through your institution.
Durable benefit and change in TCR clonality with nivolumab in a Lynch syndrome–associated glioma.
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221100863
- By:
- Publication type:
- Article
Clinical Behavior, Mutational Profile and T-Cell Repertoire of High-Grade Neuroendocrine Tumors of the Head and Neck.
- Published in:
- Cancers, 2023, v. 15, n. 9, p. 2431, doi. 10.3390/cancers15092431
- By:
- Publication type:
- Article
Detection of IDH1 Mutations in Plasma Using BEAMing Technology in Patients with Gliomas.
- Published in:
- Cancers, 2022, v. 14, n. 12, p. 2891, doi. 10.3390/cancers14122891
- By:
- Publication type:
- Article
Liquid Biopsy in Head and Neck Cancer: Current Evidence and Future Perspective on Squamous Cell, Salivary Gland, Paranasal Sinus and Nasopharyngeal Cancers.
- Published in:
- Cancers, 2022, v. 14, n. 12, p. 2858, doi. 10.3390/cancers14122858
- By:
- Publication type:
- Article
Transcriptomic Correlates of Immunologic Activation in Head and Neck and Cervical Cancer.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.714550
- By:
- Publication type:
- Article
Durable complete response after stereotactic body radiation therapy in immunotherapy-resistant non-small cell lung cancer.
- Published in:
- Journal of Cancer Research & Therapeutics, 2022, v. 18, n. 3, p. 868, doi. 10.4103/jcrt.JCRT_954_20
- By:
- Publication type:
- Article
Durable complete response after stereotactic body radiation therapy in immunotherapy-resistant non-small cell lung cancer.
- Published in:
- 2022
- By:
- Publication type:
- Letter
Long-term survival of a patient with programmed death ligand 1-negative lung adenocarcinoma and oligoprogressive disease treated with nivolumab and stereotactic body radiation therapy.
- Published in:
- 2020
- By:
- Publication type:
- Case Study
Durable intracranial and extracranial response to nivolumab with appearance of secondary resistance in a heavily pretreated patient with head and neck cancer.
- Published in:
- Head & Neck, 2019, v. 41, n. 6, p. E86, doi. 10.1002/hed.25635
- By:
- Publication type:
- Article
Systemic Treatment of Low-Grade Gliomas.
- Published in:
- Cancer & Chemotherapy Reviews, 2016, v. 11, n. 2, p. 55
- By:
- Publication type:
- Article
Plasma ctDNA Monitoring of a PTCH1-Mutant Metastatic Adult Medulloblastoma Showing a Durable Benefit With Vismodegib.
- Published in:
- Oncologist, 2024, v. 29, n. 5, p. 377, doi. 10.1093/oncolo/oyae026
- By:
- Publication type:
- Article
Safety and Efficacy of Cetuximab‐Based Salvage Chemotherapy After Checkpoint Inhibitors in Head and Neck Cancer.
- Published in:
- Oncologist, 2021, v. 26, n. 6, p. e1018, doi. 10.1002/onco.13754
- By:
- Publication type:
- Article
Nasoethmoidal Intestinal‐Type Adenocarcinoma Treated with Cetuximab: Role of Liquid Biopsy and BEAMing in Predicting Response to Anti‐Epidermal Growth Factor Receptor Therapy.
- Published in:
- Oncologist, 2019, v. 24, n. 3, p. 293, doi. 10.1634/theoncologist.2018-0387
- By:
- Publication type:
- Article
Safety and preliminary activity of pembrolizumab-carboplatin-paclitaxel in heavily pretreated and/or fragile patients with PDL1-positive recurrent/metastatic head and neck cancer.
- Published in:
- Oncology Letters, 2023, v. 25, n. 1, p. N.PAG
- By:
- Publication type:
- Article
Paclitaxel Plus Cetuximab as Induction Chemotherapy for Patients With Locoregionally Advanced Head and Neck Squamous Cell Carcinoma Unfit for Cisplatin-Based Chemotherapy.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.953020
- By:
- Publication type:
- Article
Exceptional Evolution of a Squamous Odontogenic Tumor in the Jaw: Molecular Approach.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 17, p. 9547, doi. 10.3390/ijms25179547
- By:
- Publication type:
- Article
Lapatinib plus trastuzumab in pretreated human epidermal growth factor receptor 2-positive metastatic breast cancer.
- Published in:
- Journal of Cancer Research & Therapeutics, 2014, v. 10, n. 4, p. 967, doi. 10.4103/0973-1482.138017
- By:
- Publication type:
- Article
Carbon-11 Radiolabelling of Organosulfur Compounds: <sup>11</sup>C Synthesis of the Progesterone Receptor Agonist Tanaproget.
- Published in:
- Chemistry - A European Journal, 2015, v. 21, n. 25, p. 9034, doi. 10.1002/chem.201501089
- By:
- Publication type:
- Article